Equities

Supermax Corporation Bhd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Supermax Corporation Bhd

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.18
  • Today's Change0.00 / 0.00%
  • Shares traded52.51k
  • 1 Year change--
  • Beta1.1897
Data delayed at least 15 minutes, as of May 11 2023 13:05 BST.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Supermax Corporation Berhad is an investment holding company, engaged in the production of rubber gloves. The Company is an international manufacturer, distributor and marketer of medical devices, namely medical gloves and contact lenses. It operates through four segments: Investment holding, Manufacturing of gloves, Trading of gloves and Others. It produces over 23 billion pieces of gloves in both Natural Rubber Latex Gloves and Nitrile Synthetic Latex Gloves. The Company owns range of brands, such as Supermax, Aurelia, and Maxter, which are used by hospitals, dental practices, home healthcare, laboratories, food services, tattoos and beauty industries. It distributes its gloves through distribution centers set up around the world as well as in collaboration with a wide network of distributors. Its subsidiaries include Supermax Property Holdings Sdn Bhd, Supermax Glove Manufacturing Sdn Bhd, Maxter Glove Manufacturing Sdn Bhd, Supergamma Sdn. Bhd., and others.

  • Revenue in MYR (TTM)760.47m
  • Net income in MYR-214.98m
  • Incorporated1997
  • Employees1.41k
  • Location
    Supermax Corporation BhdLot 38,Putra Industrial ParkBukit Rahaman PutraSUNGAI BULOH 40160MalaysiaMYS
  • Phone+60 361452328
  • Fax+60 361562191
  • Websitehttp://www.supermax.com.my/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.